PATENT CLAIM ANALYSIS

Application Number: 15745042
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-09
Patent Classification: ["424", "001890"]

Abstract:
The present invention relates to novel compounds that can be employed in the selective Tau detection of disorders and abnormalities associated with Tau aggregates such as Alzheimer's disease and other tauopathies using Positron Emission Tomography (PET) Imaging.

Claim (Index 1):
A compound of formula (I): and all stereoisomers and mixtures thereof, pharmaceutically acceptable salts, hydrates, solvates and polymorphs thereof; wherein is selected from a 5- to 7-membered monocyclic group and a 7- to 9-membered bicyclic group, which can optionally contain a heteroatom selected from N and O in addition to the nitrogen atom which is attached to the tricyclic group and wherein is substituted by a substituent R and is optionally substituted by a substituent R*;\n wherein \n R is selected from F\u2014, alkylene which is substituted by F, (alkylene-oxy) n - which is substituted by F, (alkylene-oxy) n -alkylene-which is substituted by F, and alkylene-oxy which is substituted by F and OH; \n R* is selected from hydroxy, methoxy, methyl and hydroxymethyl; \n n is selected from 1, 2 and 3; and \n F is [F-19]fluoro or [F-18]fluoro.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 86.0
- Lexical Diversity: 1.05128
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15112672', '14930442', '15317333', '13063525', '13089019']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7381515943131005
- 35 USC 102 Novelty (BERT): 0.5193277814202837
- Combined Prediction Score: 0.7162692130238189
- Mean Citation Score: 256.74582200000003
- Max Citation Score: 321.01422
- Similarity Product: 253.075861003486

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test